Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

Rajurkar, Mihir, Parikh, Aparna R, Solovyov, Alexander, You, Eunae, Kulkarni, Anupriya S, Chu, Chong, Xu, Katherine H, Jaicks, Christopher, Taylor, Martin S, Wu, Connie, Alexander, Katherine A, Good, Charly R, Szabolcs, Annamaria, Gerstberger, Stefanie, Tran, Antuan V, Xu, Nova, Ebright, Richard Y, Van Seventer, Emily E, Vo, Kevin D, Tai, Eric C, Lu, Chenyue, Joseph-Chazan, Jasmin, Raabe, Michael J, Nieman, Linda T, Desai, Niyati, Arora, Kshitij S, Ligorio, Matteo, Thapar, Vishal, Cohen, Limor, Garden, Padric M, Senussi, Yasmeen, Zheng, Hui, Allen, Jill N, Blaszkowsky, Lawrence S, Clark, Jeffrey W, Goyal, Lipika, Wo, Jennifer Y, Ryan, David P, Corcoran, Ryan B, Deshpande, Vikram, Rivera, Miguel N, Aryee, Martin J, Hong, Theodore S, Berger, Shelley L, Walt, David R, Burns, Kathleen H, Park, Peter J, Greenbaum, Benjamin D, Ting, David T (June 2022) Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer. Cancer Discovery, 12 (6). pp. 1462-1481. ISSN 2159-8274

[thumbnail of 10.1158.2159-8290.CD-21-1117.pdf] PDF
10.1158.2159-8290.CD-21-1117.pdf - Published Version

Download (9MB)
DOI: 10.1158/2159-8290.cd-21-1117

Abstract

Altered RNA expression of repetitive sequences and retrotransposition are frequently seen in colorectal cancer, implicating a functional importance of repeat activity in cancer progression. We show the nucleoside reverse transcriptase inhibitor 3TC targets activities of these repeat elements in colorectal cancer preclinical models with a preferential effect in p53-mutant cell lines linked with direct binding of p53 to repeat elements. We translate these findings to a human phase II trial of single-agent 3TC treatment in metastatic colorectal cancer with demonstration of clinical benefit in 9 of 32 patients. Analysis of 3TC effects on colorectal cancer tumorspheres demonstrates accumulation of immunogenic RNA:DNA hybrids linked with induction of interferon response genes and DNA damage response. Epigenetic and DNA-damaging agents induce repeat RNAs and have enhanced cytotoxicity with 3TC. These findings identify a vulnerability in colorectal cancer by targeting the viral mimicry of repeat elements. Colorectal cancers express abundant repeat elements that have a viral-like life cycle that can be therapeutically targeted with nucleoside reverse transcriptase inhibitors (NRTI) commonly used for viral diseases. NRTIs induce DNA damage and interferon response that provide a new anticancer therapeutic strategy.

Item Type: Paper
Subjects: bioinformatics
diseases & disorders > cancer
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification
diseases & disorders
bioinformatics > genomics and proteomics > genetics & nucleic acid processing
diseases & disorders > neoplasms
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > RNA expression
organism description > animal
diseases & disorders > cancer > cancer types > colorectal
organism description > animal > mammal > primates > hominids
organism description > animal > mammal > primates > hominids > human
organism description > animal > mammal
organism description > animal > mammal > primates
diseases & disorders > cancer > cancer types
CSHL Authors:
Communities: CSHL labs > Alexander lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 2 June 2022
Date Deposited: 16 Jul 2024 15:21
Last Modified: 16 Jul 2024 15:21
PMCID: PMC9167735
Related URLs:
URI: https://repository.cshl.edu/id/eprint/41612

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving